National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 02:31:46
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-5924-61 | EA - Each | 0904-5924 | b6a1585b-bc48-4aa4-8522-bc0913280508 | 1 | 2012-07-24 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0904-5924 | 0904-5924-61 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 05:41 UTC | 2022-04 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A071208-001 | HALOPERIDOL | 2MG | TABLET / ORAL | 1986-11-17 | ea99ee380514… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.